Ninety One North America, Inc. Eli Lilly & CO Transaction History

Ninety One North America, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $2.08 Million - $2.57 Million	-19,441 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $23,387 - $25,439	-219 Reduced 1.11%	19,441 $2.17 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $12.9 Million - $15 Million	-116,015 Reduced 85.51%	19,660 $2.18 Million
Q1 2019 Apr 24, 2019	SELL	$111.31 - $131.02 $32,057 - $37,733	-288 Reduced 0.21%	135,675 $17.6 Million
Q4 2018 Feb 08, 2019	SELL	$105.9 - $118.64 $6.46 Million - $7.24 Million	-60,999 Reduced 30.97%	135,963 $15.7 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $1.53 Million - $1.91 Million	-17,796 Reduced 8.29%	196,962 $21.1 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $14.6 Million - $16.7 Million	192,445 Added 862.48%	214,758 $18.3 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $65,675 - $77,526	-885 Reduced 3.81%	22,313 $1.73 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $1.9 Million - $2.04 Million	23,198	23,198 $1.96 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

Stay updated on Ninety One North America, Inc. with notifications on news.